64 related articles for article (PubMed ID: 1615760)
1. Retention of etidronate in human, dog, and rat.
Kasting GB; Francis MD
J Bone Miner Res; 1992 May; 7(5):513-22. PubMed ID: 1615760
[TBL] [Abstract][Full Text] [Related]
2. Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats.
Katsumata T; Nakamura T; Ohnishi H; Sakurama T
J Bone Miner Res; 1995 Jun; 10(6):921-31. PubMed ID: 7572316
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
[TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
6. Skeletal uptake and lifetime retention of 90Sr and 226Ra in beagles.
Raabe OG; Parks NJ
Radiat Res; 1993 Feb; 133(2):204-18. PubMed ID: 8438062
[TBL] [Abstract][Full Text] [Related]
7. Effect of disodium etidronate (EHDP) on bone ingrowth in a porous material.
Rivero DP; Skipor AK; Singh M; Urban RM; Galante JO
Clin Orthop Relat Res; 1987 Feb; (215):279-86. PubMed ID: 3100123
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
9. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
10. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
Nakamura T; Maekawa S; Morinobu S; Morinobu A; Koshiba M; Yamauchi M; Sugimoto T; Kumagai S
Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of nitrendipine. II. Distribution to and elimination from organs and tissues of rats and dogs after single or repeated administration of [14C]nitrendipine.
Krause HP; Ahr HJ; Siefert HM; Steinke W; Suwelack D
Arzneimittelforschung; 1988 Nov; 38(11):1599-604. PubMed ID: 3214443
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats.
Wronski TJ; Yen CF; Scott KS
J Bone Miner Res; 1991 Apr; 6(4):387-94. PubMed ID: 1907076
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
[TBL] [Abstract][Full Text] [Related]
15. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
16. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
[TBL] [Abstract][Full Text] [Related]
17. Prevention of ectopic bone formation by local application of ethane-1-hydroxy-1,1-diphosphonate (EHDP): an experimental study in rabbits.
Ahrengart L; Lindgren U
J Orthop Res; 1986; 4(1):18-26. PubMed ID: 3081698
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
19. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
Sieghart S
Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
[TBL] [Abstract][Full Text] [Related]
20. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A; Stephenson GF; Goldsmith CH
J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
